Ricardo Vinuya is a Rheumatology/Immunology physician. OpenAlex indexes 10 publications with 322 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1655 E Cactus Ave Ste 210
Las Vegas, NV 891837723
Telephone
702-724-8844Provider last certified this registry record 17 Nov 2025.
Industry payments
19 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Regeneron Healthcare Solutions, Inc.Program year20253 payments
- SANOFI-AVENTIS U.S. LLCProgram year20251 payment
- CSL BehringProgram year20242 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
95%Anti-IgE76.8%Omalizumab100%Xolair0%Part D + Part B<11 patientsCorticosteroid9.3%Fluticasone Propionate58%Breo Ellipta16%Trelegy Ellipta14%Symbicort12%Part D≥100 patients+ 3 more classes in this area
Metabolism & gastrointestinal
3.7%H2 blocker2%Famotidine100%Part D≥26 patientsCorticosteroid0.9%Prednisone100%Part D≥28 patients+ 1 more class in this area
Dermatology
1%Interleukin-4 Receptor alpha Antagonist0.7%Dupixent Pen61%Dupixent Syringe39%Part D<11 patientsCorticosteroid0.3%Triamcinolone Acetonide100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Preliminary results of the Puff City Program for urban teens with asthma
Journal of Allergy and Clinical Immunology
2005 - Upper airway disorders and asthma: a syndrome of airway inflammation
Annals of Allergy Asthma & Immunology
2002 - Impact of an Asthma Program on the Quality of Life of Children in an Urban Setting
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
2002
Similar KOLs
Other experts from the same institution or the same specialty.
David J. Hunter
The University of Sydney
Aziz Sheikh
Universiti Malaysia Terengganu
Nima Hafezi‐Nejad
The University of Sydney
Gelin Xu
Second Affiliated Hospital of Nanjing Medical University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”